Perspective Therapeutics (CATX) Income Statement: Revenue & Earnings

Perspective Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Perspective Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018
Revenue & Gross Profit
Revenue	0.00	1.43	5.42	10.05	9.68	7.31	5.92
Cost of Revenue	0.00	20.34	3.05	4.93	4.56	4.27	4.08
Gross Profit	0.00	-18.91	2.37	5.12	5.12	3.05	1.84
Operating Expenses
Research & Development	41.64	0.97	0.85	1.43	-1.13	-1.47	1.75
Selling, General & Administrative	26.61	21.06	5.57	7.13	7.55	6.85	6.83
Operating Expenses	92.34	22.03	6.42	8.57	8.60	8.30	8.57
Operating Income	10.46	-40.94	-6.42	-3.45	-3.48	-5.25	-6.73
Other Income/Expense
Interest Income	10.52	0.93	0.12	0.06	0.00	0.00	0.03
Interest Expense	-0.05	-0.08	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-91.84	-0.02	-2.13	0.01	0.03	-0.03	0.00
Income
Income Before Tax	-81.38	-40.11	-6.30	-3.39	-1.34	-2.20	-6.70
Income Tax Expense	-2.10	-2.65	-0.03	0.00	0.00	0.00	0.00
Net Income	-79.28	-46.51	-7.27	-3.39	-3.45	-5.14	-6.70
Net Income - Continuous Operations	-79.28	-37.46	-7.27	-3.39	0.00	0.00	0.00
Net Income - Discontinued Operations	-0.95	-9.05	0.00	0.00	0.00	0.00	0.00
EBITDA	10.46	-40.23	-6.14	-3.29	-3.33	-2.01	-6.60
EBIT	-80.43	-40.94	-6.42	-3.44	-3.48	-2.20	-6.73
Depreciation & Amortization	0.00	0.71	0.28	0.15	0.15	0.14	0.00
Earnings Per Share
Basic EPS	-1.00	-2.00	-1.00	-	-	-	-
Diluted EPS	-1.00	-2.00	-1.00	-	-	-	-
Basic Shares Outstanding	64.43	26.76	14.20	103.84	67.60	67.04	55.16
Diluted Shares Outstanding	64.43	26.76	14.20	103.84	67.60	67.04	55.16